• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Bharat Biotech’s Covaxin allowed to test booster shot

|

New Delhi, Apr 02: Bharat Biotech has been allowed to test the Covaxin booster shot by the Central Drugs Standard Control Organisation Subject Expert Committee.

Administering a third dose of the vaccine against coronavirus would provide better efficacy against the infection, the company feels.

Bharat Biotech’s Covaxin allowed to test booster shot

The booster shot is to be given six months after the second dose. The subject expert committee has approved to test it when the phase 2 trials begin. The subject experts said in its recommendation in the 148th meeting held on March 23 that the firm presented amendments in the approved Phase II clinical trial protocol for administration of booster dose after 6 months after second dose. After detailed deliberation, the committee recommended that the firm should conduct the booster dose study only in 6mcg cohort and also should follow up the subjects at least for 6 months after the third dose.

Covaxin will no longer carry out clinical trial mode labelCovaxin will no longer carry out clinical trial mode label

    J&K: 3 terrorists killed, 2 had attacked BJP leader | Oneindia News

    "Further, the firm should present the details of the primary and secondary objectives and various assessments to be carried out in the subjects. Accordingly, the firm should submit the revised clinical trial protocol for evaluation," the subject experts also said.

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X